Literature DB >> 29540298

Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.

Jodi R Paul1, Hira A Munir1, Thomas van Groen2, Karen L Gamble3.   

Abstract

Disruption of circadian rhythms is commonly reported in individuals with Alzheimer's disease (AD). Neurons in the primary circadian pacemaker, the suprachiasmatic nucleus (SCN), exhibit daily rhythms in spontaneous neuronal activity which are important for maintaining circadian behavioral rhythms. Disruption of SCN neuronal activity has been reported in animal models of other neurodegenerative disorders; however, the effect of AD on SCN neurophysiology remains unknown. In this study we examined circadian behavioral and electrophysiological changes in a mouse model of AD, using male mice from the Tg-SwDI line which expresses human amyloid precursor protein with the familial Swedish (K670N/M671L), Dutch (E693Q), Iowa (D694N) mutations. The free-running period of wheel-running behavior was significantly shorter in Tg-SwDI mice compared to wild-type (WT) controls at all ages examined (3, 6, and 10 months). At the SCN level, the day/night difference in spike rate was significantly dampened in 6-8 month-old Tg-SwDI mice, with decreased AP firing during the day and an increase in neuronal activity at night. The dampening of SCN excitability rhythms in Tg-SwDI mice was not associated with changes in input resistance, resting membrane potential, or action potential afterhyperpolarization amplitude; however, SCN neurons from Tg-SwDI mice had significantly reduced A-type potassium current (IA) during the day compared to WT cells. Taken together, these results provide the first evidence of SCN neurophysiological disruption in a mouse model of AD, and highlight IA as a potential target for AD treatment strategies in the future.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A-type potassium current; Alzheimer's disease; Circadian rhythms; Electrophysiology; Suprachiasmatic nucleus

Mesh:

Year:  2018        PMID: 29540298      PMCID: PMC5891366          DOI: 10.1016/j.nbd.2018.03.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  43 in total

Review 1.  Chronobiological approaches to Alzheimer's disease.

Authors:  Alexis M Stranahan
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

2.  Age-related decline in circadian output.

Authors:  Takahiro J Nakamura; Wataru Nakamura; Shin Yamazaki; Takashi Kudo; Tamara Cutler; Christopher S Colwell; Gene D Block
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

3.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease.

Authors:  J Steven Jacobsen; Chi-Cheng Wu; Jeffrey M Redwine; Thomas A Comery; Robert Arias; Mark Bowlby; Robert Martone; John H Morrison; Menelas N Pangalos; Peter H Reinhart; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

4.  Circadian regulation of a-type potassium currents in the suprachiasmatic nucleus.

Authors:  Jason N Itri; Andrew M Vosko; Analyne Schroeder; Joanna M Dragich; Stephan Michel; Christopher S Colwell
Journal:  J Neurophysiol       Date:  2009-11-25       Impact factor: 2.714

5.  Wavelet-based time series analysis of circadian rhythms.

Authors:  Tanya L Leise; Mary E Harrington
Journal:  J Biol Rhythms       Date:  2011-10       Impact factor: 3.182

6.  Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.

Authors:  Olaide Oyegbami; Hilary M Collins; Marie-Christine Pardon; Francis J P Ebling; David M Heery; Paula M Moran
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

7.  I(A) channels encoded by Kv1.4 and Kv4.2 regulate neuronal firing in the suprachiasmatic nucleus and circadian rhythms in locomotor activity.

Authors:  Daniel Granados-Fuentes; Aaron J Norris; Yarimar Carrasquillo; Jeanne M Nerbonne; Erik D Herzog
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

Review 8.  Translating cell biology into therapeutic advances in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

9.  Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently.

Authors:  J A van de Nes; W Kamphorst; R Ravid; D F Swaab
Journal:  Acta Neuropathol       Date:  1998-08       Impact factor: 17.088

10.  Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3.

Authors:  J R Paul; R L Johnson; R S Jope; K L Gamble
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

View more
  3 in total

Review 1.  Defining circadian disruption in neurodegenerative disorders.

Authors:  Christopher S Colwell
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

Review 2.  Evaluating Circadian Dysfunction in Mouse Models of Alzheimer's Disease: Where Do We Stand?

Authors:  Patrick W Sheehan; Erik S Musiek
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

3.  Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice.

Authors:  Allison R Fusilier; Jennifer A Davis; Jodi R Paul; Stefani D Yates; Laura J McMeekin; Lacy K Goode; Mugdha V Mokashi; Natalie Remiszewski; Thomas van Groen; Rita M Cowell; Lori L McMahon; Erik D Roberson; Karen L Gamble
Journal:  Neurobiol Dis       Date:  2021-07-30       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.